A comprehensive view of women's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Alliance Defending Freedom files suit against FDA, HHS to overturn FDA's approval of Mifeprex mifepristone abortion pill; NY Times reports abortion by medication accounts for half of abortions in US

US scientists dispel rumors that titanium dioxide in tampons is causing damage but call for further research into the impacts of overall tampon ingredients; P&G, Knix Wear and Thinx among brands facing lawsuits over ingredients, brand transparency

Phthalates show causal link to increased growth of uterine fibroids, according to Northwestern Medicine research; up to 80% of women may develop a fibroid tumor in their lifetime, 25% of them becoming symptomatic

Roche receives FDA approval for Ventana FOLR1 RxDx assay to identify epithelial ovarian cancer patients eligible for targeted treatment with ELAHERE mirvetuximab soravtansine-gynx; ovarian cancer is the eighth most common cancer in women worldwide

Over 77% of reproductive-aged women support prescription-free OTC birth control pills because of convenience; studies suggest OTC birth control would increase use of contraception, facilitate continuity of use: Kaiser Family Foundation

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count